These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 16547789)

  • 1. Variations in self-rated health among patients with HIV infection.
    Mrus JM; Schackman BR; Wu AW; Freedberg KA; Tsevat J; Yi MS; Zackin R
    Qual Life Res; 2006 Apr; 15(3):503-14. PubMed ID: 16547789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Creating a crosswalk to estimate AIDS Clinical Trials Group quality of life scores in a nationally representative sample of persons in care for HIV in the United States.
    Wu AW; Huang IC; Gifford AL; Spritzer KL; Bozzette SA; Hays RD
    HIV Clin Trials; 2005; 6(3):147-57. PubMed ID: 16255084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anthropometric differences between HIV-infected individuals prior to antiretroviral treatment and the general population from 1998-2007: the AIDS Clinical Trials Group Longitudinal Linked Randomized Trials (ALLRT) cohort and NHANES.
    Atkinson BE; Krishnan S; Cox G; Hulgan T; Collier AC
    PLoS One; 2013; 8(6):e65306. PubMed ID: 23755215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AIDS clinical trials group longitudinal linked randomized trials (ALLRT): rationale, design, and baseline characteristics.
    Smurzynski M; Collier AC; Koletar SL; Bosch RJ; Wu K; Bastow B; Benson CA
    HIV Clin Trials; 2008; 9(4):269-82. PubMed ID: 18753121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protease inhibitor combination therapy, severity of illness, and quality of life among children with perinatally acquired HIV-1 infection.
    Storm DS; Boland MG; Gortmaker SL; He Y; Skurnick J; Howland L; Oleske JM;
    Pediatrics; 2005 Feb; 115(2):e173-82. PubMed ID: 15629958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of zidovudine compared with didanosine on health status and functioning in persons with advanced HIV infection and a varying duration of prior zidovudine therapy. AIDS Clinical Trials Group 116/117 Study Group.
    Bozzette SA; Kanouse DE; Duan N; Berry S; Richman DD
    Antivir Ther; 1996 Jan; 1(1):21-32. PubMed ID: 11322256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence rate of and factors associated with loss to follow-up in a longitudinal cohort of antiretroviral-treated HIV-infected persons: an AIDS Clinical Trials Group (ACTG) Longitudinal Linked Randomized Trials (ALLRT) analysis.
    Krishnan S; Wu K; Smurzynski M; Bosch RJ; Benson CA; Collier AC; Klebert MK; Feinberg J; Koletar SL;
    HIV Clin Trials; 2011; 12(4):190-200. PubMed ID: 22044855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of antiretroviral therapy and hepatitis c co-infection on changes in lipid levels in HIV-Infected patients 48 weeks after initiation of therapy.
    Stapleton JT; Bennett K; Bosch RJ; Polgreen PM; Swindells S
    HIV Clin Trials; 2007; 8(6):429-36. PubMed ID: 18042508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Three- vs four-drug antiretroviral regimens for the initial treatment of HIV-1 infection: a randomized controlled trial.
    Gulick RM; Ribaudo HJ; Shikuma CM; Lalama C; Schackman BR; Meyer WA; Acosta EP; Schouten J; Squires KE; Pilcher CD; Murphy RL; Koletar SL; Carlson M; Reichman RC; Bastow B; Klingman KL; Kuritzkes DR;
    JAMA; 2006 Aug; 296(7):769-81. PubMed ID: 16905783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lower CD4 cell count and higher virus load, but not antiretroviral drug resistance, are associated with AIDS-defining events and mortality: an ACTG Longitudinal Linked Randomized Trials (ALLRT) analysis.
    Swindells S; Jiang H; Mukherjee AL; Winters M; Bosch RJ; Katzenstein D; Aids Clinical Trials Group
    HIV Clin Trials; 2011; 12(2):79-88. PubMed ID: 21498151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Zidovudine monotherapy versus zidovudine plus zalcitabine combination therapy in HIV-positive persons with CD4 cell counts 300-500 cells/mm3: a double-blind controlled trial. The M50003 Study Group Coordinating and Writing Committee.
    Moyle GJ; Bouza E; Antunes F; Smith D; Harris R; Warburg M; Walker M
    Antivir Ther; 1997 Dec; 2(4):229-36. PubMed ID: 11327442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of indinavir on the quality of life in patients with advanced HIV infection treated with zidovudine and lamivudine.
    Coplan PM; Cook JR; Carides GW; Heyse JF; Wu AW; Hammer SM; Nguyen BY; Meibohm AR; DiNubile MJ;
    Clin Infect Dis; 2004 Aug; 39(3):426-33. PubMed ID: 15307012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploratory analyses of efficacy data from major depressive disorder trials submitted to the US Food and Drug Administration in support of new drug applications.
    Khin NA; Chen YF; Yang Y; Yang P; Laughren TP
    J Clin Psychiatry; 2011 Apr; 72(4):464-72. PubMed ID: 21527123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel Augmentation Strategies in Major Depression.
    Martiny K
    Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of therapeutic immunization with HIV type 1 recombinant glycoprotein 160 ImmunoAG vaccine in HIV-infected individuals with CD4+ T cell counts of >or=500 and 200-400/mm3 (AIDS Clinical Trials Group Study 246/946).
    Kundu-Raychaudhuri S; Sevin A; Kilgo P; Nokta M; Pollard RB; Merigan TC
    AIDS Res Hum Retroviruses; 2001 Oct; 17(15):1371-8. PubMed ID: 11679149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patients' perceptions of the value of current vision: assessment of preference values among patients with subfoveal choroidal neovascularization--The Submacular Surgery Trials Vision Preference Value Scale: SST Report No. 6.
    Bass EB; Marsh MJ; Mangione CM; Bressler NM; Childs AL; Dong LM; Hawkins BS; Jaffee HA; Miskala P;
    Arch Ophthalmol; 2004 Dec; 122(12):1856-67. PubMed ID: 15596591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health-related quality of life in veterans and nonveterans with HIV/AIDS.
    Mrus JM; Leonard AC; Yi MS; Sherman SN; Fultz SL; Justice AC; Tsevat J
    J Gen Intern Med; 2006 Dec; 21 Suppl 5(Suppl 5):S39-47. PubMed ID: 17083499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The health-related quality of life of people living with HIV/AIDS.
    Hughes J; Jelsma J; Maclean E; Darder M; Tinise X
    Disabil Rehabil; 2004 Mar; 26(6):371-6. PubMed ID: 15204489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Access of vulnerable groups to antiretroviral therapy among persons in care for HIV disease in the United States. HCSUS Consortium. HIV Cost and Services Utilization Study.
    Andersen R; Bozzette S; Shapiro M; St Clair P; Morton S; Crystal S; Goldman D; Wenger N; Gifford A; Leibowitz A; Asch S; Berry S; Nakazono T; Heslin K; Cunningham W
    Health Serv Res; 2000 Jun; 35(2):389-416. PubMed ID: 10857469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Satisfactory cross-cultural validity of the ACTG symptom distress module in HIV-1-infected antiretroviral-naive patients.
    Regnault A; Marfatia S; Louie M; Mear I; Meunier J; Viala-Danten M
    Clin Trials; 2009 Dec; 6(6):574-84. PubMed ID: 19933717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.